HYDROXYUREA MEDAC 500 MG Իսրայել - անգլերեն - Ministry of Health

hydroxyurea medac 500 mg

tzamal bio-pharma ltd - hydroxycarbamide - capsules - hydroxycarbamide 500 mg - hydroxycarbamide - treatment of patient with chronic myeloid leukaemia (cml) in the chronic or accelerated phase of the disease.treatment of patients with essential thrombocytaemia or polycythaemia vera with a high risk for thrmboembolic complications.

Hydrea 500 mg Hard Capsules Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

hydrea 500 mg hard capsules

bristol-myers squibb pharmaceuticals uc - hydroxycarbamide - capsule, hard - 500 milligram(s) - other antineoplastic agents; hydroxycarbamide

Xromi Եվրոպական Միություն - անգլերեն - EMA (European Medicines Agency)

xromi

nova laboratories ireland limited - hydroxycarbamide - anemia, sickle cell - antineoplastic agents - prevention of vaso-occlusive complications of sickle cell disease in patients over 2 years of age

Hydrea 500 mg hard caps. Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hydrea 500 mg hard caps.

cheplapharm arzneimittel gmbh - hydroxycarbamide 500 mg - capsule, hard - 500 mg - hydroxycarbamide 500 mg - hydroxycarbamide

Hydrea 500 mg Hard Capsules Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

hydrea 500 mg hard capsules

cheplapharm arzneimittel gmbh - hydroxycarbamide - capsule, hard - other antineoplastic agents; hydroxycarbamide

Hydrea Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

hydrea

link pharmaceuticals ltd - hydroxycarbamide 500mg;   - capsule - 500 mg - active: hydroxycarbamide 500mg   excipient: citric acid dibasic sodium phosphate dodecahydrate erythrosine gelatin   indigo carmine iron oxide yellow lactose monohydrate magnesium stearate opacode black s-1-277002 titanium dioxide   - significant tumour response to hydrea (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent metastatic or inoperable carcinoma of the ovary. hydrea used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip, and carcinoma of the cervix.

Hydrea Capsules Hard 500mg Մալթա - անգլերեն - Medicines Authority

hydrea capsules hard 500mg

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - hydroxycarbamide - hard capsule - hydroxycarbamide 500 mg - antineoplastic agents